Stock Events

Stock Events

Search...

CRISPR Therapeutics (CRSP) Q4 2024 Earnings

5NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-1.49

-0.63

0.24

1.1

Details

Expected EPS

-1.408402

Actual EPS

-1.01

Surprise EPS

0.4

Surprise Percent

+28.29%

Description

CRISPR Therapeutics (CRSP) has reported earnings of -1.01 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.